Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccinations

Vaccinations

Cross-reactivity

Cross-reactivity

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Establishing a national biosafety and biosecurity agency for the United States.

Frontiers in bioengineering and biotechnology·2024

Same author

Beyond Biosecurity by Taxonomic Lists: Lessons, Challenges, and Opportunities.

Health security·2023

Same author

Beyond gain of function: strengthening oversight of research with potential pandemic pathogens.

Pathogens and global health·2023

Same author

Innovate and Stockpile: Respiratory Protection for Essential Workers in a Catastrophic Pandemic.

Health security·2023

Same author

Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern.

Frontiers in bioengineering and biotechnology·2023

Same author

Understanding Biosafety and Biosecurity in Ukraine.

Health security·2023

Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026

Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026

Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026

Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026

Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026

Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 16, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Biosecurity risks associated with vaccine platform technologies.

Jonas B Sandbrink¹, Gregory D Koblentz²

¹Future of Humanity Institute, University of Oxford, Trajan House, Mill St, Oxford, OX2 0AN, UK; Medical Sciences Division, University of Oxford, Medical Sciences Office, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.

|February 28, 2021

Summary

This summary is machine-generated.

Advancing vaccine platforms like viral vectors requires careful consideration of dual-use risks. Prioritizing RNA-based vaccines and safer modification techniques can mitigate biosecurity threats.

Keywords:

Biosecurity COVID-19 Dual-use Platform vaccine Vaccine Viral vector

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Nov 16, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Area of Science:

Biotechnology
Vaccinology
Biosecurity

Background:

Vaccine platforms, including viral vector, RNA, DNA, and recombinant protein systems, have accelerated COVID-19 vaccine development.
Further technological advancements are needed for faster vaccine development timelines.
Viral vector and DNA vaccine platforms have attracted significant research funding.

Purpose of the Study:

To analyze the dual-use potential of various vaccine platform technologies.
To identify specific biosecurity risks associated with viral vector vaccine research.
To propose strategies for minimizing dual-use risks in vaccine platform development.

Main Methods:

Comparative analysis of different vaccine platform technologies.
Assessment of dual-use concerns, particularly regarding pathogen engineering and circumvention of immunity.
Review of existing research funding trends and biosecurity governance.

Main Results:

Virally vectored vaccines present higher dual-use potential due to insights into circumventing immunity and potential for engineering dangerous viruses.
RNA-based vaccine platforms exhibit relatively low dual-use potential.
Current research funding disproportionately favors viral vector and DNA vaccine approaches.

Conclusions:

Biosecurity risks associated with vaccine platform advancement can be reduced by focusing on non-genetic modifications, using non-pathogenic vectors, and prioritizing RNA-based approaches.
Enhanced governance structures for dual-use biotechnology research are necessary.
Increased awareness of dual-use risks among scientists and research funders is crucial for mitigating anthropogenic pandemics.